Amarin Corp Plc
Market Cap
300M
Short interest (May 15)
3.0%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.38%
↑ 6.6%
Available Shares
2M
↓ 19.6%
Price Chart
Company Overview
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.